Register today for our upcoming free live webinar Defend Your Value: Syncing Evidence and Access Strategies to Prepare for US Value Assessments on Wednesday, April 18, at 1:00 pm ET. (more…)
Precision’s Ross Maclean and Jeroen Jansen encourage biopharma and medical device industries to embrace the developments around value assessment and to take a leading role in improving the transparency of cost-effectiveness evaluations. (more…)
In a feature in Pharma Live, Precision’s Jeremy Schafer and Maureen Hennessy predict that the projected growth in healthcare spend is creating an inevitable marketplace shift from volume to value. (more…)
Precision’s Jason Shafrin comments in PMLive on the importance of real-world evidence and the benefits of electronic medical records in generating evidence. (more…)
With increased biomarker and specialty lab data being incorporated into FDA submissions, drug developers are running into challenges as they prepare data that comply with new regulatory requirements. (more…)
We are pleased to announce that Med Ad News has named Precision Value & Health as a finalist for the 2018 Vision Award, to be presented as part of their annual Manny Awards ceremony on April 19 in New York City. (more…)
A new attention-grabbing PHE study, commissioned by the Alzheimer’s Association, investigates the potential savings of obtaining an earlier diagnosis. (more…)
In Part 1 of a two-part series, Todd Edgar, Alex Grosvenor, and Kellie Rademacher discuss EU biosimilar policies and their impact on the US approach, with a focus on payer coverage. (more…)
Jason Shafrin, senior director at Precision Health Economics, shares his initial thoughts on the merger of Cigna and Express Scripts with NBCNews. (more…)